Long-term air pollution exposure and poor lifestyle choices increase risk of non-alcoholic fatty liver disease

Long-term exposure to air pollution and poor lifestyle choices are key contributors to non-alcoholic fatty liver disease (NAFLD), affecting global liver health.

Acupuncture may offer limited relief from chronic spontaneous urticaria, study finds

A randomized controlled trial that included more than 300 people diagnosed with chronic spontaneous urticaria (CSU), or hives, found that acupuncture may offer limited relief

November 14, 2023

UK regulator proposes recognizing overseas medical device approvals

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.K. Medicines and Healthcare

May 24, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 – Biotech Investments

Rancho Cucamonga, 05/08/2024 / 13:05, PST/PDT – EQS Newswire – Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.